Carmell Therapeutics
Richard Upton is a General Partner at Harbor Light Capital Partners, a private investment firm seeking to invest in early stage companies. Previously, he was the founder and President of Upton Advisors, LLC, a boutique investment bank serving middle market and emerging healthcare companies throughout the United States. Mr. Upton has been advising companies since 1992 both as a senior healthcare investment banker for Salomon Brothers and later as an independent adviser. Mr. Upton has completed engagements representing aggregate transaction values in excess of $5 billion. Mr. Upton currently serves on the Boards of Alcyone Lifesciences, Courtagen Life Sciences and Carmell Therapeutics, and previously served on the Board of Home Diagnostics, Inc. (NASDAQ: HDIX – acquired by Nipro Corporation) as well as numerous other private companies. Mr. Upton is a member of the Investment Committee of the New Hampshire Charitable Foundation, and is the former Chairman of The Pine Hill Waldorf School. Mr. Upton is a founding member of Northeast Angels, an early stage angel investing group. He has also been a youth hockey coach since 2001. Mr. Upton received his MBA degree from The Darden School at the University of Virginia and a dual BA degree in Economics and English from Amherst College.
This person is not in the org chart
This person is not in any offices
Carmell Therapeutics
Carmell develops technology for producing biologically-active plastics from blood plasma for treating bone and connective tissue injuries.